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1. INTRODUCTION {#cns13381-sec-0005}
===============

Large hemispheric infarction (LHI) accounts for approximately 10% to 15% of ischemic stroke events and is associated with high mortality and poor outcome.[^1^](#cns13381-bib-0001){ref-type="ref"} Malignant brain edema is frequently seen in LHI, which could cause brain herniation and potentially death.[^1^](#cns13381-bib-0001){ref-type="ref"}, [^2^](#cns13381-bib-0002){ref-type="ref"} Brain herniation can hardly be reversed by medication alone, and timely decompressive craniectomy is often needed to reduce mortality.[^3^](#cns13381-bib-0003){ref-type="ref"}, [^4^](#cns13381-bib-0004){ref-type="ref"} It is thus important to identify indicators of malignant brain edema and potential brain herniation to prevent severe neurological dysfunction and death by early intervention.

Leukocytes, particularly neutrophils, have been reported to play an important role in experimental stroke.[^5^](#cns13381-bib-0005){ref-type="ref"}, [^6^](#cns13381-bib-0006){ref-type="ref"}, [^7^](#cns13381-bib-0007){ref-type="ref"} However, the evidence in stroke patients is still limited.[^8^](#cns13381-bib-0008){ref-type="ref"} Moreover, few studies have investigated the dynamics of leukocyte after LHI and its relationship with infarct and edema volumes, or fatal outcomes including brain herniation and death. Therefore, we aimed to investigate the potential relationship between leukocyte changes of LHI patient within one week after symptom onset and the outcome including brain herniation and death.

2. METHODS {#cns13381-sec-0006}
==========

This observational, prospective study was approved by the Ethics Committee of Xuanwu Hospital, Capital Medical University (No. 2008‐1) and complied with the Declaration of Helsinki.

2.1. Patient inclusion and exclusion criteria {#cns13381-sec-0007}
---------------------------------------------

Patients with acute LHI admitted to the neuro‐intensive care unit (NICU) of Xuanwu Hospital, Capital Medical University from January 2013 to December 2017 were enrolled in this study. Informed consents were obtained from patients or their relatives. LHI diagnosis and management were performed according to the established guidelines.[^2^](#cns13381-bib-0002){ref-type="ref"}, [^9^](#cns13381-bib-0009){ref-type="ref"} The inclusion criteria were (1) 18‐85 years old; (2) unilateral LHI involving at least 2/3 of the middle cerebral artery (MCA) territory, confirmed by computed tomography (CT) or magnetic resonance imaging (MRI); (3) within 48 hours after LHI onset; and (4) modified Rankin Scale (mRS)≤2 before symptom onset. Exclusion criteria were (1) comorbidities of serious organ dysfunction or cancer; (2) infection within 48h after symptom onset; (3) death due to reasons other than brain herniation; and (4) cerebral lobe hemorrhage \> 30 mL or ventricular hemorrhage. Brain herniation (in particular uncal herniation) was defined by deterioration of consciousness, a failure of upper brain stem function, and CT or MRI findings including severe cerebral edema, cerebral ventricular, and brain stem compression with midline shift.[^9^](#cns13381-bib-0009){ref-type="ref"}

2.2. Clinical assessment and data collection {#cns13381-sec-0008}
--------------------------------------------

Blood samples were collected on the 2nd (ie, 24h‐48h), 4th, and 7th day (D2, D4, and D7) after LHI onset for whole blood cell test, including white blood cell (WBC), neutrophil, and lymphocyte counts as well as neutrophil‐to‐lymphocyte ratio (NLR). Changes in comparison to D2 were shown as Δ. We also recorded (1) age; (2) sex; (3) history of smoking and drinking alcohol; (4) occurrence of headache, vomiting, disturbance of consciousness, and gaze palsy; (5) body temperature from D2 to D7; (6) blood pressure (BP), National Institutes of Health Stroke Scale (NIHSS), Glasgow Coma Scale (GCS), levels of procalcitonin (PCT), C‐reactive protein (CRP), neuron‐specific enolase (NSE), and blood glucose on D2 after symptom onset; (7) volume of cerebral infarction, which was measured semi‐automatically from head CT or diffusion‐weighted imaging (DWI) sequence of MRI on D2 after LHI using Fiji software and corrected with indirectly measured brain edema[^10^](#cns13381-bib-0010){ref-type="ref"}; (8) stroke etiology according to the TOAST classification (large artery atherosclerosis, cardiogenic cerebral embolism, small‐artery occlusion, other determined and undetermined etiology)[^11^](#cns13381-bib-0011){ref-type="ref"}; (8) history of atrial fibrillation, cardiac dysfunction, hypertension, and diabetes mellitus; and (9) thrombolysis, endovascular treatment, and/or decompressive craniectomy.[^2^](#cns13381-bib-0002){ref-type="ref"}, [^9^](#cns13381-bib-0009){ref-type="ref"} Patients were followed up for 6 months after symptom onset, and mRS at 6 months was recorded.

2.3. Statistical analysis {#cns13381-sec-0009}
-------------------------

Statistical analyses were performed with SPSS 22.0 (IBM Corporation, Armonk, NY). Kolmogorov‐Smirnov test was used to check the normality of continuous data. Normally distributed data were expressed as mean ± standard deviation (SD), while the non‐normally distributed data were expressed as median (interquartile range, IQR). Student\'s t‐test, Mann‐Whitney U‐test, or chi‐square test was used for intergroup comparisons, when appropriate. Repeated measures ANOVA was used to explore the group‐time effects regarding the changes of peripheral leukocyte counts within the first week poststroke. Pearson\'s correlation analysis was performed to explore the correlation between the peripheral leukocyte count and infarct/edema volumes. Spearman\'s analysis was used to investigate the correlation between peripheral leukocyte count and NIHSS, mRS, or GCS. Logistic regression analysis was used to investigate the risk factors of brain herniation and death. Receiver operating characteristic (ROC) curve was performed to find the cutoff value to predict brain herniation and death. All analyses were 2‐tailed, and *P* \< .05 was considered statistically significant.

3. RESULTS {#cns13381-sec-0010}
==========

3.1. Baseline characteristics {#cns13381-sec-0011}
-----------------------------

A total of 84 LHI patients (58 males and 26 females) were included in our study (Figure [1](#cns13381-fig-0001){ref-type="fig"}), with a mean age of 61.8 ± 14.7 years and mean NIHSS of 18.6 ± 6.2 upon admission. The patients' baseline characteristics are described in Table [1](#cns13381-tbl-0001){ref-type="table"}. Among the 84 LHI patients, 38 patients developed brain herniation within 1‐6 days, and 20 patients died. The median mRS of the patients at 6 months poststroke was 5 (IQR: 4‐6).

![Patient enrollment flow chart](CNS-26-829-g001){#cns13381-fig-0001}

###### 

Baseline characteristics of included LHI patients

                                               Overall, N = 84 (%)
  -------------------------------------------- ---------------------
  Age (y), mean ± SD                           61.8 ± 14.1
  Sex (Male/Female)                            58/26
  Mean arterial Pressure (mmHg), mean ± SD     103.4 ± 14.9
  NIHSS, mean ± SD                             18.6 ± 6.2
  GCS, median (IQR)                            9 (6‐10)
  Body Temperature (℃), median (IQR)           36.8 (36.5‐37.3)
  Hypertension                                 35 (41.7%)
  Diabetes                                     17 (20.2%)
  Hyperlipidemia                               9 (10.7%)
  Stroke history                               15 (17.9%)
  Coronary heart disease                       9 (10.7%)
  Atrial fibrillation                          29 (34.5%)
  Heart failure                                17 (20.2%)
  Smoking                                      43 (51.2%)
  Drinking alcohol                             37 (44.0%)
  Family history of stroke                     15 (17.9%)
  TOAST classification                         
  Large artery atherosclerosis                 50 (59.5%)
  Cardiac embolism                             30 (35.7%)
  Others                                       4 (4.8%)
  Postinfarct hemorrhage                       8 (9.5%)
  Infarction volume on D2 (cm^3^), mean ± SD   172.7 ± 102.6
  Edema volume on D2 (cm^3^), median (IQR)     43.4 (22.7‐97.5)
  Intravenous thrombolysis                     13 (15.5%)
  Intravascular treatment                      5 (6.0%)
  Mechanical ventilation                       46 (54.8%)
  Decompressive craniectomy                    29 (34.5%)
  mRS at 6 month, median (IQR)                 5 (4‐6)

The continuous data were described as mean ± SD for normally distributed data and as median/IQR for non‐normally distributed data. Categorical data were shown as N (%).
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Subgroup analysis revealed that patients with brain herniation were younger (57.6 ± 13.6 vs 65.3 ± 13.7 years old), presented with lower initial GCS score (median: 7 vs 9, *P* \< .01), larger cerebral infarction, and more severe brain edema compared to those without brain herniation (*P* \< .01, Table [2](#cns13381-tbl-0002){ref-type="table"}). Patients that died had higher NIHSS (21.4 ± 6.5 vs 17.7 ± 5.9) and lower GCS scores (median: 6 vs 9), higher incidence of coronary heart disease upon admission (25.0% vs 6.3%), more often received intravenous thrombolysis (30.0% vs 10.9%) or decompressive craniectomy (55.0% vs 28.1%, *P* \< .05), and exhibited larger infarcts and more severe brain edema compared to the survivors (*P* \< .01, Table [3](#cns13381-tbl-0003){ref-type="table"}).

###### 

Clinical characteristics of LHI patients with and without brain herniation

                                               Brain herniation, N (%)                       
  -------------------------------------------- ------------------------- ------------------- -----------------------------------------------
  Age (y), mean ± SD                           65.3 ± 13.7               57.6 ± 13.6         0.012[\*](#cns13381-note-0004){ref-type="fn"}
  Sex (Male/Female)                            31/15                     27/11               0.718
  Mean Arterial Pressure(mmHg), mean ± SD      105.0 ± 15.6              101.6 ± 14.1        0.294
  NIHSS, mean ± SD                             18.4 ± 6.0                18.9 ± 6.6          0.706
  GCS, median/IQR                              9 (8‐11)                  7 (5‐9)             \<0.01^\*\*^
  Temperature (℃),median/IQR                   36.9 (36.5‐37.3)          36.7 (36.4‐37.3)    0.454
  Hypertension                                 21 (45.7%)                14 (36.8%)          0.415
  Diabetes                                     8 (17.4%)                 9 (23.7%)           0.475
  Hyperlipidemia                               7 (15.2%)                 2 (5.3%)            0.142
  Stroke history                               11 (23.9%)                4 (10.5%)           0.111
  Coronary heart disease                       4 (8.7%)                  5 (13.2%)           0.51
  Atrial fibrillation                          16 (34.8%)                13 (34.2%)          0.956
  Heart failure                                12 (26.1%)                5 (13.2%)           0.142
  Smoking                                      20 (43.5%)                23 (60.5%)          0.12
  Drinking alcohol                             18 (39.1%)                19 (50.0%)          0.318
  Family history of stroke                     8 (17.4%)                 7 (18.4%)           0.902
  TOAST classification                                                                       
  Large artery atherosclerosis                 28 (60.9%)                22 (57.9%)           
  Cardiac embolism                             16 (34.8%)                14 (36.8%)           
  Others                                       2 (4.3%)                  2 (5.3%)            0.955
  Postinfarct hemorrhage                       6 (13.0%)                 2 (5.3%)            0.227
  Infarction volume on D2 (cm^3^), mean ± SD   122.9 ± 79.2              227.6 ± 98.2        \<0.01^\*\*^
  Edema volume on D2 (cm^3^), median (IQR)     31.0 (19.9‐54.3)          94.2 (38.8‐115.7)   \<0.01^\*\*^
  Intravenous thrombolysis                     4 (8.7%)                  9 (23.7%)           0.059
  Intravascular treatment                      4 (8.7%)                  1 (2.6%)            0.242
  Mechanical ventilation                       18 (39.1%)                28 (73.7%)          \<0.01^\*\*^
  Decompressive craniectomy                    6 (13.0%)                 23 (60.5%)          \<0.01^\*\*^
  mRS at 6 month (median/IQR)                  5 (3‐5)                   6 (5‐6)             \<0.01^\*\*^

The continuous data were described as mean ± SD for normally distributed data and as median/IQR for non‐normally distributed data. Categorical data were shown as N (%). The P values were obtained from Student\'s t‐test, Mann‐Whitney U‐test or chi‐square test, when appropriate.

*P* \< .05, ^\*\*^ *P* \< .01.
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###### 

Clinical characteristics of LHI patients that survived or succumbed to brain herniation

                                               Death, N (%)                           
  -------------------------------------------- ------------------ ------------------- -----------------------------------------------
  Age (y), mean ± SD                           62.1 ± 14.5        61.0 ± 13.0         0.75
  Sex (Male/Female)                            44/20              14/6                0.916
  Mean arterial pressure (mmHg), mean ± SD     104.3 ± 14.5       100.9 ± 14.7        0.376
  NIHSS, mean ± SD                             17.7 ± 5.9         21.4 ± 6.5          0.02[\*](#cns13381-note-0006){ref-type="fn"}
  GCS, median/IQR                              9 (7‐11)           6 (5‐8.8)           \<0.01^\*\*^
  Temperature (℃), median/IQR                  36.8 (36.5‐37.3)   36.7(36.3‐37.3)     0.534
  Hypertension                                 23 (35.9%)         12 (60.0%)          0.057
  Diabetes                                     11 (17.2%)         6 (30.0%)           0.213
  Hyperlipidemia                               8 (12.5%)          1 (5.0%)            0.344
  Stroke history                               12 (18.8%)         3 (15.0%)           0.702
  Coronary heart disease                       4 (6.3%)           5 (25.0%)           0.018[\*](#cns13381-note-0006){ref-type="fn"}
  Atrial fibrillation                          20 (31.3%)         9 (45.0%)           0.259
  Heart failure                                13 (20.3%)         4 (20.0%)           0.976
  Smoking                                      32 (50.0%)         11 (55.0%)          0.696
  Drinking alcohol                             28 (43.8%)         9 (45.0%)           0.922
  Family history of stroke                     12 (18.8%)         3 (15.0%)           0.702
  TOAST classification                                                                
  Large artery atherosclerosis                 39 (60.9%)         11 (55.0%)           
  Cardiac embolism                             21 (32.8%)         9 (45.0%)            
  Others                                       4 (6.3%)           \<0.001             0.373
  Postinfarct hemorrhage                       7 (10.9%)          1 (5.0%)            0.43
  Infarction volume on D2 (cm^3^), mean ± SD   152.6 ± 87.1       234.4 ± 123.8       \<0.01^\*\*^
  Edema volume on D2 (cm^3^), median (IQR)     43.3 (23.4‐90.2)   64.7 (18.2‐113.9)   \<0.01^\*\*^
  Intravenous thrombolysis                     7 (10.9%)          6 (30.0%)           0.04[\*](#cns13381-note-0006){ref-type="fn"}
  Intravascular treatment                      4 (6.3%)           1 (5.0%)            0.837
  Mechanical ventilation                       32 (50.0%)         14 (70.0%)          0.117
  Decompressive craniectomy                    18 (28.1%)         11 (55.0%)          0.027[\*](#cns13381-note-0006){ref-type="fn"}
  mRS, median/IQR                              5 (3‐5)            6 (6‐6)             \<0.01^\*\*^

The continuous data were described as mean ± SD for normally distributed data and as median/IQR for non‐normally distributed data. Categorical data were shown as N (%). The P values were obtained from Student\'s t‐test, Mann‐Whitney U‐test or chi‐square test, when appropriate.

*P* \< .05, ^\*\*^ *P* \< .01.
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3.2. Leukocyte dynamics in LHI patients {#cns13381-sec-0012}
---------------------------------------

Compared to the patients with benign courses, patients developing herniation or dying from stroke showed higher WBC and neutrophil counts throughout the first week poststroke, as well as higher body temperature on D4 and D7 (*P* \< .05, Figure [2](#cns13381-fig-0002){ref-type="fig"}). No significant difference in percentages of neutrophils/lymphocytes or NLR was found between groups (Figure [S1](#cns13381-sup-0001){ref-type="supplementary-material"}). ΔWBC and Δneutrophil counts are presented in Figure [S2](#cns13381-sup-0001){ref-type="supplementary-material"}. Repeated measures ANOVA revealed significant group‐time effects between WBC/neutrophil and death (*P* \< .01 and *P* \< .05, respectively), but not between WBC/neutrophil and brain herniation (*P* \> .05). NSE level was higher in the herniation group \[33.9 (19.7‐58.3) ng/mL vs 22.0 (15.1‐39.9) ng/mL, *P* \< .05\], but no statistically significant differences in PCT or CRP levels were observed between groups.

![Dynamics of peripheral leukocytes and body temperature in different groups of LHI patients. \*^/\#^ *P* \< .05, \*\*^/\#\#^ *P* \< .01, \*\*\**P* \< .001](CNS-26-829-g002){#cns13381-fig-0002}

3.3. D2 WBC and neutrophil counts relate to volumes of brain infarct and edema {#cns13381-sec-0013}
------------------------------------------------------------------------------

Pearson\'s correlation analysis showed that both WBC and neutrophil counts on D2 positively correlated with cerebral infarct (*R^2^* = 0.23 and *R^2^* = 0.22, respectively, *P* \< .01) and edema volumes (both *R^2^* = 0.15, *P* \< .01; Figure [3](#cns13381-fig-0003){ref-type="fig"}A i‐iv). None of the other parameters like lymphocyte count, neutrophil‐lymphocyte ratio (NLR), or NSE level was significantly correlated with the volume of cerebral infarct or edema (*P* \> .05). Spearman analysis revealed that D2 neutrophil count negatively correlated with D2 GCS (ρ = −0.234, *P* \< .05), but neither with NIHSS nor mRS (*P* \> .05).

![(A) Linear fitting of WBC and neutrophil counts on D2 in relation to volumes of cerebral infarction and edema in LHI patients; (B) ROC curves of WBC and neutrophil counts on D2 to predict brain herniation (i and iii, respectively) and death (ii and iv, respectively)](CNS-26-829-g003){#cns13381-fig-0003}

3.4. D2 neutrophil count relates to fatal outcome of LHI patients {#cns13381-sec-0014}
-----------------------------------------------------------------

Univariate logistic regression revealed that both WBC and neutrophil counts on D2 were significantly related to brain herniation \[odds ratio (OR) = 1.166, 95% CI: 1.019‐1.334, *P* = .025; OR = 1.201, 95% CI: 1.041‐1.386, *P* = .012, respectively\], and D2 neutrophil count significantly related to death (OR = 1.233, 95% CI: 1.053‐1.444, *P* = .009).

For WBC, the area under its ROC curve of D2 WBC count to predict brain herniation is 0.626 (*P* = .047, 95% CI: 0.507‐0.746) with the Youden Index of 9.75 × 10^9^ (sensitivity: 84.2%, specificity: 41.3%), and the area under its ROC curve to predict death is 0.635 (*P* = .070, 95% CI: 0.499‐0.770) (Figure [3](#cns13381-fig-0003){ref-type="fig"}B i, ii). Patients with D2 WBC \> 9.75 × 10^9^/L had a 3.8‐fold risk of brain herniation compared to patients with D2 WBC ≤ 9.75 × 10^9^/L (95% CI: 1.3‐10.7, *P* = .011). Increased Δ~2‐4~ WBC count was associated with brain herniation (odds ratio = 2.9, 95% CI: 1.1‐7.5, *P* \< .05), but not death (*P* \> .05).

For D2 neutrophil count, the area under its ROC curve to predict brain herniation was 0.654 (*P* = .016, 95% CI: 0.537‐0.770) with the Youden Index of 7.14 × 10^9^/L (sensitivity: 93.1%, specificity: 37.5%), and the area under its ROC curve to predict death was 0.678 (*P* = .017, 95% CI: 0.548‐0.809) with the Youden Index of 7.79 × 10^9^/L (sensitivity: 90.0%, specificity: 39.1%) (Figure [3](#cns13381-fig-0003){ref-type="fig"}B iii, iv). Patients with D2 neutrophil \> 7.14 × 10^9^/L had a 7.5‐fold risk of brain herniation compared to patients with D2 neutrophil ≤ 7.14 × 10^9^/L (95% CI: 2.0‐28.1, *P* = .001). Patients with D2 neutrophil \> 7.79 × 10^9^/L had a 5.8‐fold risk of death compared to patients with D2 neutrophil ≤ 7.79 × 10^9^/L (95% CI: 1.2‐27.0, *P* = .015). Increased Δ~2‐4~ neutrophil count was associated with brain herniation (odds ratio = 2.7, 95% CI: 1.0‐6.7, *P* \< .05), but not death (*P* = .52).

4. DISCUSSION {#cns13381-sec-0015}
=============

Our study found that LHI patients developing brain herniation or succumbing to stroke showed higher WBC and neutrophils counts within the first week after stroke. Neutrophil count on D2 after stroke significantly related to infarct and edema volumes as well as GCS, and also related to fatal outcome (brain herniation and death).

Animal studies revealed that neutrophils rapidly increase within a few hours after stroke and peak at 24‐48h before gradually returning to baseline.[^12^](#cns13381-bib-0012){ref-type="ref"}, [^13^](#cns13381-bib-0013){ref-type="ref"}, [^14^](#cns13381-bib-0014){ref-type="ref"} They contribute to the disruption of blood‐brain barrier and aggravate ischemic injury and edema by releasing reactive oxygen species, proteases (metalloproteinases, elastase, cathepsin G, etc), cytokines (eg, IL‐6, IL‐8, TNF‐α), and chemokines (CCL2, CCL3, CCL5, etc).[^13^](#cns13381-bib-0013){ref-type="ref"}, [^15^](#cns13381-bib-0015){ref-type="ref"} They also play a multifaceted role in various stroke‐related aspects such as thrombosis and poststroke infection.[^12^](#cns13381-bib-0012){ref-type="ref"}, [^13^](#cns13381-bib-0013){ref-type="ref"} Our results showed peripheral neutrophil count peaked on D2 after stroke and then gradually decreased on D4 in LHI patients without brain herniation. Similar changes were observed in stroke survivors. In contrast, neutrophil count further increased until D4 in patients with brain herniation. Hence, it may be proposed that neutrophil infiltration is more severe and persists for a longer time in malignant cerebral edema or prior to death (Figure [S3](#cns13381-sup-0001){ref-type="supplementary-material"}).

In our study, D7 neutrophil counts peaked across groups, which might be related to the frequent poststroke pneumonia. Poststroke pneumonia might be a respiratory syndrome due to complex bacterial, chemical, and immunological factors, and could not be prevented by prophylactic antibiosis alone, even for patients at high aspiration risk.[^16^](#cns13381-bib-0016){ref-type="ref"} All patients with known infection upon admission were excluded in our study. Moreover, body temperature on D2, as well as the levels of PCT and CRP, was comparable between groups. Thus, potential effects of early infection on D2 neutrophil count are unlikely. However, patients that developed pneumonia thereafter were not excluded due to high incidence in each group (\>90%), and exclusion of such patients would therefore dramatically decrease sample size and might further cause a selection bias.

Our results provide preliminary evidence for a linear relationship between neutrophil count and infarct/edema volumes, which has not been established previously. Furthermore, neutrophil count was found to significantly relate to brain herniation and death after LHI. Various imaging modalities such as perfusion CT, PET, and MRI within 6‐24h also have been reported to reliably predict a malignant LHI course mainly through evaluating infarct and edema volumes.[^17^](#cns13381-bib-0017){ref-type="ref"}, [^18^](#cns13381-bib-0018){ref-type="ref"}, [^19^](#cns13381-bib-0019){ref-type="ref"} However, availability and feasibility of these imaging modalities are limited due to practical reasons early after symptom onset in many stroke units. Other biomarkers such as NLR, PCT, and NSE have been suggested to predict the severity of ischemic stroke,[^20^](#cns13381-bib-0020){ref-type="ref"}, [^21^](#cns13381-bib-0021){ref-type="ref"}, [^22^](#cns13381-bib-0022){ref-type="ref"} but none of them was found to relate to infarct or edema volumes in this study. Hence, neutrophil count could be of clinical use as a simple yet sensitive indicator for LHI patients at risk of fatal outcome and would be helpful to indicate the necessity and timing of specific imaging and subsequent additional therapeutic measures such as careful dehydration and decompressive craniectomy to reduce intracranial pressure. However, specificity of D2 neutrophil count as a predictor of fatal outcome was poor (\<40%), indicating that other risk factors also contribute to fatal outcome after LHI.

Our study has some limitations. First, the modest sample size limits the data interpretation. Second, other causes of peripheral leukocytosis cannot be completely excluded despite controlling for signs of infection upon admission. Third, only limited data were obtained in the hyper‐acute stage after stroke because many patients arrived relatively late, and any analysis at very early time points is therefore not possible. Fourth, longitudinal imaging was not performed on D4 and D7 in order to reduce frequent transportation of those critically ill patients. Therefore, it is unknown whether the increase of WBC and neutrophil counts on D7 relates primarily to the growth of infarct or edema, or the frequently observed pneumonia.

In conclusion, our study provides preliminary evidence that increased peripheral neutrophil count early after LHI relates to infarct and edema volumes, and can indicate fatal outcome of LHI patients, thus may help guiding acute management of LHI such as reduction of intracranial pressure. As a promising target in stroke therapy, neutrophils may also be used to identify patients that could benefit from adjunctive antiinflammatory therapies.[^15^](#cns13381-bib-0015){ref-type="ref"} Future studies with larger numbers of patients are required to verify this hypothesis and shall also focus specifically on earlier time points after stroke (≤24h).
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